Fairmount Funds Management LLC
Position in DNTH — Dianthus Therapeutics, Inc. /DE/
CIK 1802528
WEST CONSHOHOCKEN, PA
Position in DNTH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$247,325,378
+$34,404,310 QoQ
Shares Held
2,537,191
0.0% QoQ
Ownership
4.54%
of shares outstanding
% of Portfolio
16.35%
of 13F equity value
Holder Rank
#5
of 269 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNTH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fairmount Funds Management LLC holds $1,512,967,792 across 12 Biotechnology names. DNTH ranks #2 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORKA |
Oruka Therapeutics, Inc.
|
3,705,262 | $352,629,784 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
This page
|
2,537,191 | $247,325,378 | |
| 3 | DMRA |
Damora Therapeutics, Inc.
|
8,713,000 | $226,625,130 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
5,503,418 | $212,982,276 | |
| 5 | JBIO |
Jade Biosciences, Inc.
|
4,553,494 | $101,178,636 | |
| 6 | ELVN |
Enliven Therapeutics, Inc.
|
1,855,644 | $94,173,933 | |
| 7 | VRDN |
Viridian Therapeutics, Inc.\DE
|
5,090,928 | $93,520,347 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
2,359,025 | $59,872,054 |
All Filings in DNTH
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $247,325,378 | 2,537,191 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $212,921,068 | 2,537,191 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $88,073,641 | 2,137,191 | Shares | Sole | 2026-02-17 | |
| 2025-11-21 | $88,687,870 | 2,139,635 | Shares | Sole | 2025-11-25 | |
| 2025-09-30 | $130,137,965 | 3,307,191 | Shares | Sole | 2025-11-14 | |
| 2025-09-11 | $153,410,688 | 4,052,052 | Shares | Sole | 2025-09-15 | |
| 2025-06-30 | $50,434,968 | 2,707,191 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $48,990,534 | 2,700,691 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $58,875,063 | 2,700,691 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $73,944,919 | 2,700,691 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $71,502,221 | 2,762,837 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $82,885,110 | 2,762,837 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $20,056,431 | 1,928,503 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $26,362,636 | 1,928,503 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||